Abstract:Nuclear factor–B (NF-B) plays a central role in inflammatory responses, and its physiologic functions are essential for cell survival and proliferation. Currently, drugs targeting NF-B inhibition have not yet been applied in clinical practice. We investigated the physiologic effect of a novel NF-B inhibitory compound, 1 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivative (INH #1), on three inflammatory animal models. The pharmacokinetics were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. Acute hepatitis was induced by administrating lipopolysaccharide (LPS) and D-(+)-galactosamine hydrochloride followed by the analysis of survival time and inflammatory mediators. Collagen-induced arthritis (CIA) was induced by immunization with type II collagen (CII), and serum-transfer arthritis (STA) was caused by injecting K/BxN mice serum. Clinical and histologic scores were evaluated in both arthritis models. Immune cell subset analysis, CII-induced interferon-gamma (IFN-) production and proliferation, and measurement of anti-CII IgG antibodies were performed in the CIA model. In the acute hepatitis model, INH #1 suppressed tumor necrosis factor- α (TNF- α ) production and prevented early death in a dose-dependent manner. INH #1 significantly attenuated arthritis scores and joint inflammation in both arthritis models. Additionally, in the CIA model, dendritic cells (DCs) in the regional lymph nodes were decreased in the treated mice and antigen-induced IFN- production and cell proliferation in splenocytes were inhibited, whereas the titers of anti-CII IgG antibodies were comparable regardless of the treatment. Here we revealed that INH #1 exerted anti-inflammatory effects in vivo via inhibition of inflammatory mediators and suppression of cellular immune responses. This compound could be a novel candidate for inhibition of NF-B in certain inflammatory diseases. SIGNIFICANCE STATEMENT A novel nuclear factor–B (NF-B) inhibitory compound, 1 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivative (INH #1), which retains physiologically essential NF-B bioactivity, suppressed inflammation in three different mouse models: the acute hepatitis model, the collagen-induced arthritis model, and the K/BxN serum-transfer arthritis model. These results suggest that this compound could be a novel and potent anti-inflammatory agent.

Anti-inflammatory Effects of a Novel Peptide Designed to Bind with NF-κB P50 Subunit

Yak Bone Collagen-Derived Anti-Inflammatory Bioactive Peptides Alleviate Lipopolysaccharide-Induced Inflammatory by Inhibiting the Nf-Kb Signaling Pathway and Nitric Oxide Production

Effect of Α-Pinene on Nuclear Translocation of NF-κB in THP-1 Cells

The Anti-inflammatory Effect of the CXCR4 Antagonist-N15P Peptide and Its Modulation on Inflammation-Associated Mediators in LPS-Induced PBMC.

Peptide TaY Attenuates Inflammatory Responses by Interacting with Myeloid Differentiation 2 and Inhibiting NF-κB Signaling Pathway

LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.

Inhibition of Inflammation by a P38 MAP Kinase Targeted Cell Permeable Peptide

Dose-dependent anti-inflammatory and neuroprotective effects of an α β 3 integrin-binding peptide

A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.

A Novel Peptide Derived from Human Pancreatitis-Associated Protein Inhibits Inflammation in Vivo and in Vitro and Blocks NF-kappa B Signaling Pathway.

C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation

The Peptide Lycosin-I Attenuates TNF-α-induced Inflammation in Human Umbilical Vein Endothelial Cells Via IκB/NF-κB Signaling Pathway

Design and Development of a Novel Peptide for Treating Intestinal Inflammation

Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity

A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects

In vitro and in vivo biological evaluation of Lappaconitine derivatives as potential anti-inflammatory agents

Anti-Inflammatory Effects of a Novel Nuclear Factor-{kappa}B Inhibitory Derivative Derived from PyrazoloPyrimidine in Three Inflammation Models

Synthesis, Anti-Inflammatory Activities, and Molecular Docking Study of Novel Pyxinol Derivatives as Inhibitors of NF-κB Activation

Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1

The In Vitro And In Vivo Anti-Inflammatory Effects Of A Phthalimide Ppar-Gamma Agonist

Analysis of the Activity and Function of the Broad-Spectrum Inflammatory Chemokine Inhibition Leader: P1 Peptide